专题:Mechanisms of Drug-Induced Hepatotoxicity

This cluster of papers focuses on the mechanisms, risk factors, biomarkers, and management of drug-induced hepatotoxicity, with a specific emphasis on acetaminophen-induced liver injury. It covers topics such as oxidative stress, mitochondrial dysfunction, HLA genotype associations, idiosyncratic reactions, and the role of liver transplantation in severe cases.
最新文献
Acute-on-chronic liver failure and immune dysregulation: Systemic inflammation and immunoparesis paradox

article Full Text OpenAlex

Drug-induced autoimmune hepatitis due to atorvastatin: a complex clinical case and literature review

article Full Text OpenAlex

Nutrigenomics of fat-soluble vitamins and micronutrients in hepatocyte lipotoxicity and MASLD

article Full Text OpenAlex

Changes in paracetamol and leucovorin use after a White House briefing

article Full Text OpenAlex

Adverse drug reaction due to concomitant vaccine administration of Covishield and Hepatitis-B in a patient with multidrug allergies

article Full Text OpenAlex

Review of MASLD in Adults—Reply

article Full Text OpenAlex

A Case of Psychosis Caused by Long‐Term Overdose of Compound Paracetamol and Amantadine Hydrochloride Capsules

article Full Text OpenAlex

Reversible massive ascites from amiodarone hepatotoxicity

article Full Text OpenAlex

Prevalence and outcome of children with acute viral hepatitis using complementary and alternative medications (CAM) presenting to a tertiary care center of North India: A prospective observational study

article Full Text OpenAlex

Azathioprine-induced acute generalized exanthematous pustulosis in a woman with autoimmune hepatitis

article Full Text OpenAlex

近5年高被引文献
Global burden of liver disease: 2023 update

review Full Text OpenAlex 1845 FWCI386.8371

Nirmatrelvir Plus Ritonavir: First Approval

review Full Text OpenAlex 293 FWCI28.0572

EASL Clinical Practice Guidelines on acute-on-chronic liver failure

article Full Text OpenAlex 286 FWCI57.1625

EASL Clinical Practice Guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis

article Full Text OpenAlex 285 FWCI37.5214

Recommendations for the Management of Drug–Drug Interactions Between the COVID‐19 Antiviral Nirmatrelvir/Ritonavir (Paxlovid) and Comedications

review Full Text OpenAlex 253 FWCI44.2845

Dissecting the Crosstalk Between Nrf2 and NF-κB Response Pathways in Drug-Induced Toxicity

review Full Text OpenAlex 241 FWCI18.1393

Acute-on-Chronic Liver Failure Clinical Guidelines

review Full Text OpenAlex 220 FWCI27.9326

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

article Full Text OpenAlex 215 FWCI32.9

International Journal of Pharmacy and Pharmaceutical Science

paratext Full Text OpenAlex 206 FWCI0

Acetaminophen Hepatotoxicity: Paradigm for Understanding Mechanisms of Drug-Induced Liver Injury

article Full Text OpenAlex 183 FWCI82.8675